Relevant bibliographies by topics / Anti-amyloidogenic compounds

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Book chapters

Academic literature on the topic 'Anti-amyloidogenic compounds'

Author: Grafiati
Published: 9 March 2023
Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Anti-amyloidogenic compounds.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Anti-amyloidogenic compounds"

1

Porzoor, Afsaneh, Benjamin Alford, Helmut Hügel, Danilla Grando, Joanne Caine, and Ian Macreadie. "Anti-Amyloidogenic Properties of Some Phenolic Compounds." Biomolecules 5, no. 2 (2015): 505–27. http://dx.doi.org/10.3390/biom5020505.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Hirohata, Mie, Kenjiro Ono, and Masahito Yamada. "Non-Steroidal Anti-Inflammatory Drugs as Anti-Amyloidogenic Compounds." Current Pharmaceutical Design 14, no. 30 (2008): 3280–94. http://dx.doi.org/10.2174/138161208786404173.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Skibiszewska and Jankowska. "Can Short Peptides Be Inhibitors of Serum Amyloid a Protein Aggregation?" Proceedings 22, no. 1 (2019): 38. http://dx.doi.org/10.3390/proceedings2019022038.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Tan, Mario A., Mark Wilson D. Lagamayo, Grecebio Jonathan D. Alejandro, and Seong Soo A. An. "Anti-Amyloidogenic and Cyclooxygenase Inhibitory Activity of Guettarda speciosa." Molecules 24, no. 22 (2019): 4112. http://dx.doi.org/10.3390/molecules24224112.

Full text
Abstract:
Guettarda speciosa is known in traditional folk medicine for treating cough, cold, sore throat, fever, wounds, epilepsy, and headaches. To discover the scientific pharmacological potential of G. speciosa, we explore its anti-inflammatory, cytotoxicity, and inhibition of amyloid-beta (Aβ) aggregation effects. Cyclooxygenase assay of the G. speciosa CHCl3 (GSC) extract and G. speciosa MeOH (GSM) extract are more selective to COX-1 inhibition with a 50% inhibitory concentration (IC50) of 3.56 μg/mL for the GSC extract and 4.98 μg/mL for the GSM extract. Neuroblastoma SH-SY5Y inhibition and thiofl
APA, Harvard, Vancouver, ISO, and other styles
5

Yeo, Ji-Yun, Seul Lee, Min Sung Ko, et al. "Anti-Amyloidogenic Effects of Metasequoia glyptostroboides Fruits and Its Active Constituents." Molecules 28, no. 3 (2023): 1017. http://dx.doi.org/10.3390/molecules28031017.

Full text
Abstract:
Alzheimer’s disease (AD) is a serious neurodegenerative brain disease that interferes with daily life. The accumulation of beta-amyloid (Aβ), along with oxidative stress-inducing neurocellular apoptosis, has been considered one of the causes of AD. Thus, the purpose of this study is to find natural products that can reduce Aβ accumulation. The ethanol extract of Metasequoia glyptostroboides Hu & Cheng fruits (Cupressaceae) significantly reduced the aggregation of Aβ into oligomers and fibrils determined by Thioflavin T (ThT) assay. The solvent-partitioned ethyl acetate layer was further se
APA, Harvard, Vancouver, ISO, and other styles
6

Jaipuria, Aadya, Madison Castillo, James Boksanski, et al. "Extended Chalcones: Synthesis, In Vitro Analysis, and In Vivo Testing Against a Drosophila melanogaster Alzheimer’s Disease Model." Chemistry 6, no. 6 (2024): 1477–94. http://dx.doi.org/10.3390/chemistry6060089.

Full text
Abstract:
Alzheimer’s Disease (AD) is the most common form of dementia in individuals over the age of 65. There is no known prevention for the progression of the disease, although the FDA recently approved two drugs for AD. The exact etiology of AD is still under debate; however, it is commonly associated with the aggregation of amyloid-beta (Aβ) plaques in the brain. Recently some extended chalcones were reported to be potential anti-amyloidogenic agents. In this study, a larger library of extended chalcone analogs were synthesized with modifications on both rings. These were tested using the Thioflavi
APA, Harvard, Vancouver, ISO, and other styles
7

Quiroz, Jose Paredes, Andi Zeng, Michelle Young, et al. "Homotaurine and Curcumin Analogues as Potential Anti-Amyloidogenic Agents." Chemistry 5, no. 1 (2023): 223–41. http://dx.doi.org/10.3390/chemistry5010018.

Full text
Abstract:
Currently, there is neither a cure for Alzheimer’s disease (AD) nor a way to stop the progressive death of neuronal cells associated with this devastating aliment. To date, there are only medications that temporarily slow its progression, and do not interfere with its pathogenesis. One of the hallmarks of AD is the presence of amyloid-beta plaques derived from the metabolism of the amyloid precursor protein, via the cleavage by beta followed by gamma secretase. Homotaurine, a naturally occurring small molecule found in some seaweeds, and curcumin, a phenolic antioxidant found in Curcuma longa,
APA, Harvard, Vancouver, ISO, and other styles
8

Marvastizadeh, Narges, Bahareh Dabirmanesh, Reza H. Sajedi та Khosro Khajeh. "Anti-amyloidogenic effect of artemin on α-synuclein". Biological Chemistry 401, № 10 (2020): 1143–51. http://dx.doi.org/10.1515/hsz-2019-0446.

Full text
Abstract:
Abstractα-Synuclein fibrillation is now regarded as a major pathogenic process in Parkinson’s disease and its proteinaceous deposits are also detected in other neurological disorders including Alzheimer's disease. Therefore anti-amyloidegenic compounds may delay or prevent the progression of synucleinopathies disease. Molecular chaperones are group of proteins which mediate correct folding of proteins by preventing unsuitable interactions which may lead to aggregation. The objective of this study was to investigate the anti-amyloidogenic effect of molecular chaperone artemin on α-synuclein. As
APA, Harvard, Vancouver, ISO, and other styles
9

Ziaunys, Mantas, and Vytautas Smirnovas. "Exploring Epigallocatechin-3-Gallate Autoxidation Products: Specific Incubation Times Required for Emergence of Anti-Amyloid Properties." Antioxidants 11, no. 10 (2022): 1887. http://dx.doi.org/10.3390/antiox11101887.

Full text
Abstract:
Amyloidogenic protein/peptide aggregation into fibrillar aggregates is associated with multiple amyloidoses, including widespread neurodegenerative disorders. Despite years of research and a well-understood mechanism, there are still very few treatments available for the increasing number of amyloid-related disorders. In recent years, the search for potential anti-aggregation compounds has shifted toward naturally occurring molecules, with one of the most promising being epigallocatechin-3-gallate (EGCG). This polyphenolic compound was shown to inhibit the aggregation of several amyloidogenic
APA, Harvard, Vancouver, ISO, and other styles
10

Lakey-Beitia, Johant, Jagadeesh Kumar D., Muralidhar Hegde, and K. S. Rao. "Carotenoids as Novel Therapeutic Molecules Against Neurodegenerative Disorders: Chemistry and Molecular Docking Analysis." International Journal of Molecular Sciences 20, no. 22 (2019): 5553. http://dx.doi.org/10.3390/ijms20225553.

Full text
Abstract:
Alzheimer’s disease (AD) is the most devastating neurodegenerative disorder that affects the aging population worldwide. Endogenous and exogenous factors are involved in triggering this complex and multifactorial disease, whose hallmark is Amyloid-β (Aβ), formed by cleavage of amyloid precursor protein by β- and γ-secretase. While there is no definitive cure for AD to date, many neuroprotective natural products, such as polyphenol and carotenoid compounds, have shown promising preventive activity, as well as helping in slowing down disease progression. In this article, we focus on the chemistr
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Anti-amyloidogenic compounds"

1

SIRONI, ERIKA. "Nuclear Magnetic Resonance characterization of Beta-amyloid peptides and their interactions with anti-amyloidogenic compounds." Doctoral thesis, Università degli Studi di Milano-Bicocca, 2013. http://hdl.handle.net/10281/41573.

Full text
Abstract:
Neurotoxic aggregates generated by amyloid beta peptides (Abeta) represent one of the main pathological features of Alzheimer’s Disease (AD). Nowadays many natural and synthetic compounds able to prevent Abeta peptide toxicity and aggregation have already been identified. Several of these compounds are not soluble in water, are chemically unstable and/or show pharmacological activities not directly correlated to AD. Among these, tetracycline, rosmarinic acid and curcumin, were analyzed for their ability to bind Abeta peptides. For this purpose NMR spectroscopy has been mainly employed, with th
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Anti-amyloidogenic compounds"

1

"Rational design, synthesis and biological evaluation of dual- binding reversible inhibitors of cholinesterase’s with mild inhibitory potency toward monoamine oxidase B." In Book of Abstracts - RAD 2025 Conference. RAD Centre, Niš, Serbia, 2025. https://doi.org/10.21175/rad.abstr.book.2025.21.3.

Full text
Abstract:
Alzheimer’s disease (AD) is neurodegenerative disease that is the cause of 60-70% of dementia cases. The major symptoms of AD involve progressive decline of cognitive and motor skills, caused by neuropathological changes, including elevation of oxidative stress, shrinkage of neurons, formation of Aβ plaques and neurofibrillary tangles in the central nervous system (CNS) and disruption of glutamatergic and cholinergic neurotransmission systems. In AD, the nerve terminal disruption is observed in immediate vicinity of Aβ plaques. Peripheral ionic site of AChE promotes aggregation of Aβ peptides
APA, Harvard, Vancouver, ISO, and other styles
2

Pattnaik, Prachi, Chetan Panda, Tarun Minocha, Sanjeev Kumar Yadav, Namrata Dwivedi, and Sandeep Kumar Singh. "Bacopa monnieri and Neural Health: An Indian Herb." In Traditional Medicine for Neuronal Health. BENTHAM SCIENCE PUBLISHERS, 2023. http://dx.doi.org/10.2174/9789815040197123010011.

Full text
Abstract:
The disorders of the central nervous system are increasingly recognized as one of the most prevalent disorders in the present world. It has been envisaged that neurological disorders will be of great concern in the present and future populations worldwide. The different neurological disorders may be associated with signs, such as loss of memory, impaired brain function, cognitive deficits, etc. The occurrence of such degenerative diseases of the nervous system certainly imposes medical and public health burdens on populations worldwide. The multifactorial nature of such neural disorders entail
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Anti-amyloidogenic compounds' for particular source types:
Journal articles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography